Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action - PubMed (original) (raw)
Comparative Study
. 1998 May 1;58(9):1860-5.
Affiliations
- PMID: 9581825
Comparative Study
Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action
N S Kumar et al. Cancer Res. 1998.
Abstract
The uterine endometrium responds to unopposed estrogen stimulation with rapid cell proliferation. Progesterone protects the endometrium against the hyperplastic effects of estradiol (E2) through progesterone receptors (PRs), of which two isoforms are expressed: human (h) PRA and PRB. hPRB has a longer NH2 terminus and may function differently from hPRA. Thus, the relative expression of hPRA:hPRB is likely to be important for the action of progesterone. We hypothesized that the hPRA:hPRB ratios may be abnormal in endometrial cancer, leading to a lack of normal progesterone protection against the growth-promoting effects of E2. To test this hypothesis, well-differentiated Ishikawa endometrial cancer cells were compared to poorly differentiated Hec50 and KLE cells. Reverse transcription-PCR was chosen as a sensitive method to detect transcripts for the two forms of PR. The relative expression of PR isoforms under hormonal stimulation was determined by Western blotting. Transient transfections of hPRA and hPRB into endometrial cells allowed the evaluation of the transcriptional activity of each isoform independently on reporter gene transcription under the control of a simple progesterone response element-containing promoter. The effect of coexpressing the estrogen receptor on PR expression was also studied. Ishikawa cells (well-differentiated) express both hPRA and hPRB. Both isoforms, but predominantly hPRB, are up-regulated by E2 and not by tamoxifen or the pure antiestrogen ICI 182,780. Hec50 and KLE cells (poorly differentiated) express only hPRA. No hPRB is present in the poorly differentiated cells, and it is not induced by estrogen receptor expression and/or estrogen treatment. In all cells, hPRB expression, whether endogenous or produced as a result of transfection, acts as a stronger transcription factor than hPRA on a simple progesterone-dependent promoter. We speculate that down-regulation of hPRB may predict for poorly differentiated endometrial cancers that do not respond to progestin therapy.
Similar articles
- Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D, Kumar NS, Wolf DM, Leslie KK. Dai D, et al. Am J Obstet Gynecol. 2001 Apr;184(5):790-7. doi: 10.1067/mob.2001.113844. Am J Obstet Gynecol. 2001. PMID: 11303185 - [Regulation of human progesterone receptor isoforms A and B in uterine endometrial carcinoma by estrogen and insulin-like growth factor-1].
Zhang X, Wei L, Wang J, Tu Z. Zhang X, et al. Zhonghua Yi Xue Za Zhi. 2002 Jun 25;82(12):836-9. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12126534 Chinese. - [Endocrinological contribution for invasion and metastasis in gynecological cancers].
Fujimoto J. Fujimoto J. Nihon Sanka Fujinka Gakkai Zasshi. 1996 Aug;48(8):633-43. Nihon Sanka Fujinka Gakkai Zasshi. 1996. PMID: 8808831 Review. Japanese. - The endometrium: effects of estrogen and estrogen-progestogen replacement therapy.
Samsioe G. Samsioe G. Int J Fertil Menopausal Stud. 1994;39 Suppl 2:84-92. Int J Fertil Menopausal Stud. 1994. PMID: 7874191 Review.
Cited by
- EGFR isoforms and gene regulation in human endometrial cancer cells.
Albitar L, Pickett G, Morgan M, Wilken JA, Maihle NJ, Leslie KK. Albitar L, et al. Mol Cancer. 2010 Jun 25;9:166. doi: 10.1186/1476-4598-9-166. Mol Cancer. 2010. PMID: 20579378 Free PMC article. - Progesterone receptor A and B isoforms in the human breast and its disorders.
Ariga N, Suzuki T, Moriya T, Kimura M, Inoue T, Ohuchi N, Sasano H. Ariga N, et al. Jpn J Cancer Res. 2001 Mar;92(3):302-8. doi: 10.1111/j.1349-7006.2001.tb01095.x. Jpn J Cancer Res. 2001. PMID: 11267940 Free PMC article. - Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.
Chu Y, Wang Y, Zhang G, Chen H, Dowdy SC, Xiong Y, Liu F, Zhang R, Li J, Jiang SW. Chu Y, et al. Cell Mol Life Sci. 2014 Sep;71(17):3393-408. doi: 10.1007/s00018-014-1580-9. Epub 2014 Feb 15. Cell Mol Life Sci. 2014. PMID: 24531693 Free PMC article. - Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma.
Shao R. Shao R. Ecancermedicalscience. 2013 Dec 18;7:381. doi: 10.3332/ecancer.2013.381. Ecancermedicalscience. 2013. PMID: 24386010 Free PMC article. Review. - Differential expression of progesterone receptor isoforms A and B in the normal ovary, and in benign, borderline, and malignant ovarian tumors.
Akahira J, Suzuki T, Ito K, Kaneko C, Darnel AD, Moriya T, Okamura K, Yaegashi N, Sasano H. Akahira J, et al. Jpn J Cancer Res. 2002 Jul;93(7):807-15. doi: 10.1111/j.1349-7006.2002.tb01323.x. Jpn J Cancer Res. 2002. PMID: 12149147 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials